Pharmaceutical Executive
In response to concerns about the low level of patient participation in clinical trials, the British Medical Association has launched an internet resource aimed at encouraging more patients to take part. Aimed at healthcare professionals, the site explains how different types of trials are conducted and spells out their ethical and best practices requirements.
In response to concerns about the low level of patient participation in clinical trials, the British Medical Association has launched an internet resource aimed at encouraging more patients to take part. Aimed at healthcare professionals, the site explains how different types of trials are conducted and spells out their ethical and best practices requirements.
BMA's head of science and ethics, Dr. Vivienne Nathanson, warns that low patient participation can hinder medical research. She says, "The involvement and cooperation of doctors and patients is crucial to the success of a clinical trial."
The site includes several initiatives that should increase the number of trial participants, including links to online registers, where patients can find details of studies suitable for them. It also suggests to their doctors that they take part. One of the initiatives mentioned in the resource is that patients should be able to access online trial registers, so they can find out what trials are taking place. That way, they can suggest to their doctor that they would like to participate
The site also recommends that healthcare providers give internet resources for clinical trials more widespread publicity, such as in hospital waiting rooms and doctors' offices.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.